Home Aminos (R)-5,6-Dihydro-5-(methylamino)-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Z)-2-butenedioate

(R)-5,6-Dihydro-5-(methylamino)-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Z)-2-butenedioate

CAS No.:
179386-44-8
Catalog Number:
AG00ABYY
Molecular Formula:
C15H17N3O5
Molecular Weight:
319.3126
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1mg
≥98%
1 week
United States
$91
- +
5mg
98%
1 week
United States
$161
- +
10mg
≥98%
1 week
United States
$265
- +
25mg
98%
1 week
United States
$446
- +
50mg
98%
1 week
United States
$793
- +
100mg
98%
1 week
United States
$1335
- +
Product Description
Catalog Number:
AG00ABYY
Chemical Name:
(R)-5,6-Dihydro-5-(methylamino)-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Z)-2-butenedioate
CAS Number:
179386-44-8
Molecular Formula:
C15H17N3O5
Molecular Weight:
319.3126
MDL Number:
MFCD09832637
IUPAC Name:
(Z)-but-2-enedioic acid;(10R)-10-(methylamino)-1,3-diazatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-trien-2-one
InChI:
InChI=1S/C11H13N3O.C4H4O4/c1-12-8-5-7-3-2-4-9-10(7)14(6-8)11(15)13-9;5-3(6)1-2-4(7)8/h2-4,8,12H,5-6H2,1H3,(H,13,15);1-2H,(H,5,6)(H,7,8)/b;2-1-/t8-;/m1./s1
InChI Key:
VOJRMYBBPKNLLI-ORHWHDKWSA-N
SMILES:
OC(=O)/C=C\C(=O)O.CN[C@@H]1Cc2cccc3c2n(C1)c(=O)[nH]3
UNII:
2OI87T3R1B
Properties
Complexity:
400  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
1  
Exact Mass:
319.117g/mol
Formal Charge:
0
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
4  
Isotope Atom Count:
0
Molecular Weight:
319.317g/mol
Monoisotopic Mass:
319.117g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
119A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists. Psychopharmacology 20120101
Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: studies with preferential antagonists in squirrel monkeys. The Journal of pharmacology and experimental therapeutics 20100801
The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100601
The dopamine D3 receptor partial agonist CJB 090 inhibits the discriminative stimulus but not the reinforcing or priming effects of cocaine in squirrel monkeys. Psychopharmacology 20090901
The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats. Psychopharmacology 20090401
Motor sequence learning in primate: role of the D2 receptor in movement chunking during consolidation. Behavioural brain research 20090302
Asymmetric synthesis of tetrahydroquinolin-3-ols via CoCl2-catalyzed reductive cyclization of nitro cyclic sulfites with NaBH4. Organic letters 20090219
Sumanirole versus placebo or ropinirole for the adjunctive treatment of patients with advanced Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society 20070315
A comparison of sumanirole versus placebo or ropinirole for the treatment of patients with early Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society 20070315
Efficacy and tolerability of sumanirole in restless legs syndrome: a phase II, randomized, double-blind, placebo-controlled, dose-response study. Sleep medicine 20070301
The effects of a selective dopamine D2 receptor agonist on behavioral and pathological outcome in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated squirrel monkeys. The Journal of pharmacology and experimental therapeutics 20050901
Sumanirole, a highly dopamine D2-selective receptor agonist: in vitro and in vivo pharmacological characterization and efficacy in animal models of Parkinson's disease. The Journal of pharmacology and experimental therapeutics 20050901
Sumanirole Pharmacia. Current opinion in investigational drugs (London, England : 2000) 20030101
Properties